Navigation Links
Lipitor Reduces Risk of Major Cardiovascular Events

Lipitor could help in controlling heart disease, and other major cardiovascular risk factors, which are commonly called as ‘Metabolic Syndrome’. //

According to the new study that has been published today on the Lancet's Web site, larger doses of Lipitor, the cholesterol-lowering drug of Pfizer further might lower the so-called ‘bad’ cholesterol and prevent serious heart or circulatory conditions in certain patients.

The researchers in the study have shown that patients with coronary heart disease and metabolic syndrome who took 80 milligrams of Lipitor a day had lower low-density lipoprotein, or ‘bad’ cholesterol, than patients on 10 milligrams a day. They explained in their findings that patients on a higher-dose had a 9.5% risk of death from coronary heart disease, heart attack, cardiac arrest or stroke, when compared to 13% in respect with others.

Prakash Deedwania, a professor of cardiology at the University of California School of Medicine in San Francisco and lead author of the study said, “This clearly suggests that the higher dose of Lipitor provides substantially greater benefits”.

It is reported that Pfizer, had funded the study, as it is seeking to expand the market for Lipitor. The drug is already the world's top-selling drug, which had generated sales of $12.2 billion in 2005 for Pfizer, but now faces stiff competition from generics, like Zocor from Merck & Co, which is slated as the 6th best-selling treatment in the world that had generated a revenue of around $4.4 billion last year, and AstraZeneca's Crestor, which had sales of $387 million in the first quarter of 2006.

The researchers explained that they had conducted the study by enrolling 5,584 patients with coronary heart disease and metabolic syndrome at 256 centers around 14 countries and monitored them for about five years. They explained that high levels of low-density lipoprotein are a risk factor for heart and circulatory diseases. Deedwania explained that the diagnosis of metabolic syndrome is usually made in patients with three cardiovascular risk factors, like insulin resistance, obesity, and large waistline, high blood pressure and lipoprotein imbalances. He further stressed that these days the condition is “at epidemic proportions throughout the world” and is directly related to obesity of the population.

Andre Scheen, a Belgian researcher, writing in a comment that accompanied the study, said, “The TNT findings suggest that the presence of metabolic syndrome might help to select patients who will best benefit from aggressive lipid-lowering therapy.

According to the World Health Organization, diseases due to cardiovascular condition like heart attacks and strokes are the leading cause of death and kill about 17 million people a year.



Source-Medinia
VIK
'"/>




Related medicine news :

1. Drug Reduces Risk of Clogged Arteries, Veins
2. Sunshine Reduces MS Risk
3. Estrogen in Food Reduces Cancer Risk
4. Dental Procedure Reduces Preterm Births
5. Vaccine Reduces antibiotic-resistant infections in Children
6. Eating Fiber Reduces The Risk Of Heart Disease
7. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
8. Anti-tobacco Advertising Can Reduces smoking Among Teens
9. Eating Fish Reduces Heart Disease
10. Co-trimoxazole Use Reduces Childhood AIDS –Related Death
11. NSAIDS, Reduces The Risk Of Oral Cancer But Causes Heart Attacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2016)... ... 2016 , ... DDi , a Makro company, makes ... its expertise in eClinical Solutions. DDi has built its solution competency with a ... global clients. DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains ...
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of ... Evangeline Parishes. The purpose of these scholarships is to encourage applicants to pursue ... to seek employment within these two parishes. , “We have available jobs in ...
(Date:2/12/2016)... Falls Church, VA (PRWEB) , ... February 12, 2016 , ... CDRH Enforcement Trends: , ... http://www.fdanews.com/cdrhenforcementtrends , As Winston Churchill said, “Those who don’t learn ... 2015 will show what to expect when they come knocking this year. But that takes ...
(Date:2/12/2016)... Angeles, CA (PRWEB) , ... February 12, 2016 , ... ... With a hectic schedule, a demanding job, and no time to decompress, Rabinowitz found ... she dedicated herself to meditation for its impact on her life, implementing a 20-minute-per-day ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ... Zuckerberg San Francisco General Hospital on April 5-7. The series is a multi-day, ... new habits. The workshops cover a broad range of topics, including coaching skills, ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 12, 2016  Sequent Medical, Inc. announced today that ... evaluate the safety and effectiveness of the WEB™ Aneurysm ... intracranial aneurysms.  Prof Laurent Spelle , MD, Head ... Paris, France and Principal Investigator of the ... France and Germany.  Although patients with ruptured ...
(Date:2/12/2016)... 2016  OMS Supply, a large provider of oral ... today the recent launching of their new company website. ... features that enhance the user experience and enable practitioners ... --> --> Despite the ... that started in early 2016, they have already made ...
(Date:2/11/2016)... Feb. 11, 2016 - ... in Personalized Medicine and Cancer Therapy. - European ... Diagnostic Testing Markets. - Key Diagnostic Testing Markets. ... Molecular Diagnostics in Genetic Testing. - Molecular Diagnostics ... - Over-the-Counter Diagnostic Products World Markets. - ...
Breaking Medicine Technology: